Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Ultra-high-field arterial spin labelling MRI for non-contrast assessment of cortical lesion perfusion in multiple sclerosis.

Dury RJ, Falah Y, Gowland PA, Evangelou N, Bright MG, Francis ST.

Eur Radiol. 2018 Oct 2. doi: 10.1007/s00330-018-5707-5. [Epub ahead of print]

PMID:
30280247
2.

Dual infectious brainstem encephalitis with Aspergillus flavus and Haemophilus influenza in an immunocompetent patient.

Papathanasiou A, Abdel-Fahim R, Evangelou N.

Neurol Sci. 2018 Oct;39(10):1795-1796. doi: 10.1007/s10072-018-3469-0. Epub 2018 Jun 13. No abstract available.

PMID:
29948465
3.

Validating the portal population of the United Kingdom Multiple Sclerosis Register.

Middleton RM, Rodgers WJ, Chataway J, Schmierer K, Rog D, Galea I, Akbari A, Tuite-Dalton K, Lockhart-Jones H, Griffiths D, Noble DG, Jones KH, Al-Din A, Craner M, Evangelou N, Harman P, Harrower T, Hobart J, Husseyin H, Kasti M, Kipps C, McDonnell G, Owen C, Pearson O, Rashid W, Wilson H, Ford DV.

Mult Scler Relat Disord. 2018 Aug;24:3-10. doi: 10.1016/j.msard.2018.05.015. Epub 2018 May 25.

PMID:
29860199
4.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N; Jacqueline Palace on behalf of the MAGNIMS study group.

Nat Rev Neurol. 2018 Mar 20;14(4):213. doi: 10.1038/nrneurol.2018.39.

PMID:
29582852
5.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N, Palace J; MAGNIMS study group.

Nat Rev Neurol. 2018 Apr;14(4):199-213. doi: 10.1038/nrneurol.2018.14. Epub 2018 Mar 9. Review. Erratum in: Nat Rev Neurol. 2018 Mar 20;14 (4):213.

PMID:
29521337
6.

Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial.

McKee JB, Cottriall CL, Elston J, Epps S, Evangelou N, Gerry S, Kennard C, Kong Y, Koelewyn A, Kueker W, Leite MI, Palace J, Craner M.

Mult Scler. 2017 Nov 1:1352458517742979. doi: 10.1177/1352458517742979. [Epub ahead of print]

PMID:
29172994
7.

Abnormal task driven neural oscillations in multiple sclerosis: A visuomotor MEG study.

Barratt EL, Tewarie PK, Clarke MA, Hall EL, Gowland PA, Morris PG, Francis ST, Evangelou N, Brookes MJ.

Hum Brain Mapp. 2017 May;38(5):2441-2453. doi: 10.1002/hbm.23531. Epub 2017 Feb 27.

PMID:
28240392
8.

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.

Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, Klawiter EC, Mainero C, Massacesi L, McFarland H, Nelson F, Ontaneda D, Rauscher A, Rooney WD, Samaraweera AP, Shinohara RT, Sobel RA, Solomon AJ, Treaba CA, Wuerfel J, Zivadinov R, Sicotte NL, Pelletier D, Reich DS; NAIMS Cooperative.

Nat Rev Neurol. 2016 Dec;12(12):714-722. doi: 10.1038/nrneurol.2016.166. Epub 2016 Nov 11. Review.

PMID:
27834394
9.

Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom.

Rodríguez Cruz PM, Matthews L, Boggild M, Cavey A, Constantinescu CS, Evangelou N, Giovannoni G, Gray O, Hawkins S, Nicholas R, Oppenheimer M, Robertson N, Zajicek J, Rothwell PM, Palace J.

JAMA Neurol. 2016 Aug 1;73(8):954-60. doi: 10.1001/jamaneurol.2016.1463.

PMID:
27366989
10.

The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T.

Samaraweera AP, Clarke MA, Whitehead A, Falah Y, Driver ID, Dineen RA, Morgan PS, Evangelou N.

J Neuroimaging. 2017 Jan;27(1):114-121. doi: 10.1111/jon.12367. Epub 2016 Jun 14.

PMID:
27300318
11.

A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.

Cronin MJ, Wharton S, Al-Radaideh A, Constantinescu C, Evangelou N, Bowtell R, Gowland PA.

MAGMA. 2016 Jun;29(3):543-57. doi: 10.1007/s10334-016-0560-5. Epub 2016 Apr 25.

12.

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.

Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, Rovira A, Sastre-Garriga J, Tintorè M, Frederiksen JL, Gasperini C, Palace J, Reich DS, Banwell B, Montalban X, Barkhof F; MAGNIMS Study Group.

Lancet Neurol. 2016 Mar;15(3):292-303. doi: 10.1016/S1474-4422(15)00393-2. Epub 2016 Jan 26. Review.

13.

Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions.

Mistry N, Abdel-Fahim R, Samaraweera A, Mougin O, Tallantyre E, Tench C, Jaspan T, Morris P, Morgan PS, Evangelou N.

Mult Scler. 2016 Sep;22(10):1289-96. doi: 10.1177/1352458515616700. Epub 2015 Dec 10.

PMID:
26658816
14.

Imaging gray matter with concomitant null point imaging from the phase sensitive inversion recovery sequence.

Mougin O, Abdel-Fahim R, Dineen R, Pitiot A, Evangelou N, Gowland P.

Magn Reson Med. 2016 Nov;76(5):1512-1516. doi: 10.1002/mrm.26061. Epub 2015 Nov 24.

15.

Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial.

McKee JB, Elston J, Evangelou N, Gerry S, Fugger L, Kennard C, Kong Y, Palace J, Craner M.

BMJ Open. 2015 Nov 9;5(11):e009200. doi: 10.1136/bmjopen-2015-009200.

16.

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.

Juryńczyk M, Weinshenker B, Akman-Demir G, Asgari N, Barnes D, Boggild M, Chaudhuri A, D'hooghe M, Evangelou N, Geraldes R, Illes Z, Jacob A, Kim HJ, Kleiter I, Levy M, Marignier R, McGuigan C, Murray K, Nakashima I, Pandit L, Paul F, Pittock S, Selmaj K, de Sèze J, Siva A, Tanasescu R, Vukusic S, Wingerchuk D, Wren D, Leite I, Palace J.

J Neurol. 2016 Jan;263(1):140-9. doi: 10.1007/s00415-015-7952-8. Epub 2015 Nov 3.

17.

Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial.

Rice CM, Marks DI, Ben-Shlomo Y, Evangelou N, Morgan PS, Metcalfe C, Walsh P, Kane NM, Guttridge MG, Miflin G, Blackmore S, Sarkar P, Redondo J, Owen D, Cottrell DA, Wilkins A, Scolding NJ.

Trials. 2015 Oct 14;16:463. doi: 10.1186/s13063-015-0953-1.

18.

New imaging language skills required in MS.

Sormani MP, Evangelou N.

Neurology. 2015 Sep 29;85(13):1096-7. doi: 10.1212/WNL.0000000000001978. Epub 2015 Aug 28. No abstract available.

PMID:
26320204
19.

Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.

Samaraweera AP, Cohen SN, Akay EM, Evangelou N.

Mult Scler. 2016 Jan;22(1):122-4. doi: 10.1177/1352458515597568. Epub 2015 Jul 28.

PMID:
26219664
20.

Improved detection of focal cortical lesions using 7T magnetisation transfer imaging in patients with multiple sclerosis.

Abdel-Fahim R, Mistry N, Mougin O, Blazejewska A, Pitiot A, Retkute R, Gowland P, Evangelou N.

Mult Scler Relat Disord. 2014 Mar;3(2):258-65. doi: 10.1016/j.msard.2013.10.004. Epub 2013 Oct 19.

PMID:
25878014
21.

Subjective discomfort in children receiving 3 T MRI and experienced adults' perspective on children's tolerability of 7 T: a cross-sectional questionnaire survey.

Chou IJ, Tench CR, Gowland P, Jaspan T, Dineen RA, Evangelou N, Abdel-Fahim R, Whitehouse WP, Constantinescu CS.

BMJ Open. 2014 Oct 15;4(10):e006094. doi: 10.1136/bmjopen-2014-006094.

22.

Headache: two views on the right approach in general practice.

Taylor T, Evangelou N, Porter H, Hamilton W, Kernick D.

Br J Gen Pract. 2014 Sep;64(626):475-6. doi: 10.3399/bjgp14X681541. No abstract available.

23.

Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab.

Kitley J, Evangelou N, Küker W, Jacob A, Leite MI, Palace J.

J Neurol Sci. 2014 Apr 15;339(1-2):223-5. doi: 10.1016/j.jns.2014.01.035. Epub 2014 Feb 4.

PMID:
24576801
24.

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.

International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, Fontaine B, Hemmer B, Martin C, Zipp F, D'Alfonso S, Martinelli-Boneschi F, Taylor B, Harbo HF, Kockum I, Hillert J, Olsson T, Ban M, Oksenberg JR, Hintzen R, Barcellos LF; Wellcome Trust Case Control Consortium 2 (WTCCC2); International IBD Genetics Consortium (IIBDGC), Agliardi C, Alfredsson L, Alizadeh M, Anderson C, Andrews R, Søndergaard HB, Baker A, Band G, Baranzini SE, Barizzone N, Barrett J, Bellenguez C, Bergamaschi L, Bernardinelli L, Berthele A, Biberacher V, Binder TM, Blackburn H, Bomfim IL, Brambilla P, Broadley S, Brochet B, Brundin L, Buck D, Butzkueven H, Caillier SJ, Camu W, Carpentier W, Cavalla P, Celius EG, Coman I, Comi G, Corrado L, Cosemans L, Cournu-Rebeix I, Cree BA, Cusi D, Damotte V, Defer G, Delgado SR, Deloukas P, di Sapio A, Dilthey AT, Donnelly P, Dubois B, Duddy M, Edkins S, Elovaara I, Esposito F, Evangelou N, Fiddes B, Field J, Franke A, Freeman C, Frohlich IY, Galimberti D, Gieger C, Gourraud PA, Graetz C, Graham A, Grummel V, Guaschino C, Hadjixenofontos A, Hakonarson H, Halfpenny C, Hall G, Hall P, Hamsten A, Harley J, Harrower T, Hawkins C, Hellenthal G, Hillier C, Hobart J, Hoshi M, Hunt SE, Jagodic M, Jelčić I, Jochim A, Kendall B, Kermode A, Kilpatrick T, Koivisto K, Konidari I, Korn T, Kronsbein H, Langford C, Larsson M, Lathrop M, Lebrun-Frenay C, Lechner-Scott J, Lee MH, Leone MA, Leppä V, Liberatore G, Lie BA, Lill CM, Lindén M, Link J, Luessi F, Lycke J, Macciardi F, Männistö S, Manrique CP, Martin R, Martinelli V, Mason D, Mazibrada G, McCabe C, Mero IL, Mescheriakova J, Moutsianas L, Myhr KM, Nagels G, Nicholas R, Nilsson P, Piehl F, Pirinen M, Price SE, Quach H, Reunanen M, Robberecht W, Robertson NP, Rodegher M, Rog D, Salvetti M, Schnetz-Boutaud NC, Sellebjerg F, Selter RC, Schaefer C, Shaunak S, Shen L, Shields S, Siffrin V, Slee M, Sorensen PS, Sorosina M, Sospedra M, Spurkland A, Strange A, Sundqvist E, Thijs V, Thorpe J, Ticca A, Tienari P, van Duijn C, Visser EM, Vucic S, Westerlind H, Wiley JS, Wilkins A, Wilson JF, Winkelmann J, Zajicek J, Zindler E, Haines JL, Pericak-Vance MA, Ivinson AJ, Stewart G, Hafler D, Hauser SL, Compston A, McVean G, De Jager P, Sawcer SJ, McCauley JL.

Nat Genet. 2013 Nov;45(11):1353-60. doi: 10.1038/ng.2770. Epub 2013 Sep 29.

25.

Postpartum headache: diagnostic considerations.

Lim SY, Evangelou N, Jürgens S.

Pract Neurol. 2014 Apr;14(2):92-9. doi: 10.1136/practneurol-2013-000664. Epub 2013 Aug 28. Review.

PMID:
23986526
26.

The current state-of-the-art of spinal cord imaging: applications.

Wheeler-Kingshott CA, Stroman PW, Schwab JM, Bacon M, Bosma R, Brooks J, Cadotte DW, Carlstedt T, Ciccarelli O, Cohen-Adad J, Curt A, Evangelou N, Fehlings MG, Filippi M, Kelley BJ, Kollias S, Mackay A, Porro CA, Smith S, Strittmatter SM, Summers P, Thompson AJ, Tracey I.

Neuroimage. 2014 Jan 1;84:1082-93. doi: 10.1016/j.neuroimage.2013.07.014. Epub 2013 Jul 14. Review.

27.

Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter.

Mistry N, Abdel-Fahim R, Mougin O, Tench C, Gowland P, Evangelou N.

Mult Scler. 2014 Feb;20(2):227-33. doi: 10.1177/1352458513496344. Epub 2013 Jul 15.

PMID:
23858017
28.

Ultra-high-field MR imaging in multiple sclerosis.

Filippi M, Evangelou N, Kangarlu A, Inglese M, Mainero C, Horsfield MA, Rocca MA.

J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):60-6. doi: 10.1136/jnnp-2013-305246. Epub 2013 Jun 27. Review.

PMID:
23813636
29.

The current state-of-the-art of spinal cord imaging: methods.

Stroman PW, Wheeler-Kingshott C, Bacon M, Schwab JM, Bosma R, Brooks J, Cadotte D, Carlstedt T, Ciccarelli O, Cohen-Adad J, Curt A, Evangelou N, Fehlings MG, Filippi M, Kelley BJ, Kollias S, Mackay A, Porro CA, Smith S, Strittmatter SM, Summers P, Tracey I.

Neuroimage. 2014 Jan 1;84:1070-81. doi: 10.1016/j.neuroimage.2013.04.124. Epub 2013 May 14. Review.

30.

Role of oral teriflunomide in the management of multiple sclerosis.

Tanasescu R, Evangelou N, Constantinescu CS.

Neuropsychiatr Dis Treat. 2013;9:539-53. doi: 10.2147/NDT.S31248. Epub 2013 Apr 22.

31.

Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain.

Mistry N, Dixon J, Tallantyre E, Tench C, Abdel-Fahim R, Jaspan T, Morgan PS, Morris P, Evangelou N.

JAMA Neurol. 2013 May;70(5):623-8. doi: 10.1001/jamaneurol.2013.1405.

PMID:
23529352
32.

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.

Matthews L, Marasco R, Jenkinson M, Küker W, Luppe S, Leite MI, Giorgio A, De Stefano N, Robertson N, Johansen-Berg H, Evangelou N, Palace J.

Neurology. 2013 Apr 2;80(14):1330-7. doi: 10.1212/WNL.0b013e3182887957. Epub 2013 Mar 13.

33.

The only way to manage neurodegeneration in MS is to prevent it with effective anti-inflammatory therapy: yes.

Evangelou N.

Mult Scler. 2012 Dec;18(12):1680-1. doi: 10.1177/1352458512464687. No abstract available.

PMID:
23235776
34.

Association between pathological and MRI findings in multiple sclerosis.

Filippi M, Rocca MA, Barkhof F, Brück W, Chen JT, Comi G, DeLuca G, De Stefano N, Erickson BJ, Evangelou N, Fazekas F, Geurts JJ, Lucchinetti C, Miller DH, Pelletier D, Popescu BF, Lassmann H; Attendees of the Correlation between Pathological MRI findings in MS workshop.

Lancet Neurol. 2012 Apr;11(4):349-60. doi: 10.1016/S1474-4422(12)70003-0. Epub 2012 Mar 19. Review.

PMID:
22441196
35.

Rationing and deprivation: disease-modifying therapies for multiple sclerosis in the United Kingdom.

Owens T, Evangelou N, Whynes DK.

Eur J Health Econ. 2013 Apr;14(2):315-21. doi: 10.1007/s10198-012-0378-7. Epub 2012 Jan 24.

PMID:
22270579
36.

Optimisation of T₂*-weighted MRI for the detection of small veins in multiple sclerosis at 3 T and 7 T.

Dixon JE, Simpson A, Mistry N, Evangelou N, Morris PG.

Eur J Radiol. 2013 May;82(5):719-27. doi: 10.1016/j.ejrad.2011.09.023. Epub 2011 Dec 3.

PMID:
22138119
37.

Primary care direct access MRI for the investigation of chronic headache.

Taylor TR, Evangelou N, Porter H, Lenthall R.

Clin Radiol. 2012 Jan;67(1):24-7. doi: 10.1016/j.crad.2011.02.006. Epub 2011 Nov 16.

PMID:
22088325
38.

Primary malignant fibrous histiocytoma: a rare case.

Katsourakis A, Noussios G, Hadjis I, Evangelou N, Chatzitheoklitos E.

Case Rep Med. 2011;2011:134801. doi: 10.1155/2011/134801. Epub 2011 Oct 18.

39.

Focal multiple sclerosis lesions abound in 'normal appearing white matter'.

Mistry N, Tallantyre EC, Dixon JE, Galazis N, Jaspan T, Morgan PS, Morris P, Evangelou N.

Mult Scler. 2011 Nov;17(11):1313-23. doi: 10.1177/1352458511415305. Epub 2011 Jul 25.

PMID:
21788249
40.

Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions.

Tallantyre EC, Dixon JE, Donaldson I, Owens T, Morgan PS, Morris PG, Evangelou N.

Neurology. 2011 Feb 8;76(6):534-9. doi: 10.1212/WNL.0b013e31820b7630.

41.

3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions.

Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Morris PG, Evangelou N.

J Magn Reson Imaging. 2010 Oct;32(4):971-7. doi: 10.1002/jmri.22115.

PMID:
20882628
42.

Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis.

Tallantyre EC, Bø L, Al-Rawashdeh O, Owens T, Polman CH, Lowe JS, Evangelou N.

Mult Scler. 2010 Apr;16(4):406-11. doi: 10.1177/1352458510364992. Epub 2010 Mar 9.

PMID:
20215480
43.

A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions.

Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Evangelou N, Morris PG.

Invest Radiol. 2009 Sep;44(9):491-4. doi: 10.1097/RLI.0b013e3181b4c144.

PMID:
19652606
44.

Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease.

Tallantyre EC, Bø L, Al-Rawashdeh O, Owens T, Polman CH, Lowe J, Evangelou N.

Brain. 2009 May;132(Pt 5):1190-9. doi: 10.1093/brain/awp106.

PMID:
19420101
45.

Holding personal information in a disease-specific register: the perspectives of people with multiple sclerosis and professionals on consent and access.

Baird W, Jackson R, Ford H, Evangelou N, Busby M, Bull P, Zajicek J.

J Med Ethics. 2009 Feb;35(2):92-6. doi: 10.1136/jme.2008.025304.

PMID:
19181880
46.

Spinal cord neuronal pathology in multiple sclerosis.

Gilmore CP, DeLuca GC, Bö L, Owens T, Lowe J, Esiri MM, Evangelou N.

Brain Pathol. 2009 Oct;19(4):642-9. doi: 10.1111/j.1750-3639.2008.00228.x. Epub 2008 Dec 19.

PMID:
19170682
47.

A case of neuromyelitis optica with gadolinium-enhancing brain lesions and Parinaud syndrome.

Gilmore CP, Jacob A, Evangelou N.

Arch Neurol. 2009 Jan;66(1):140; author reply 140-1. doi: 10.1001/archneurol.2008.520. No abstract available.

PMID:
19139317
48.

Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging.

Gilmore CP, Geurts JJ, Evangelou N, Bot JC, van Schijndel RA, Pouwels PJ, Barkhof F, Bö L.

Mult Scler. 2009 Feb;15(2):180-8. doi: 10.1177/1352458508096876. Epub 2008 Oct 9.

PMID:
18845658
49.

Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord.

Gilmore CP, Donaldson I, Bö L, Owens T, Lowe J, Evangelou N.

J Neurol Neurosurg Psychiatry. 2009 Feb;80(2):182-7. doi: 10.1136/jnnp.2008.148767. Epub 2008 Oct 1.

PMID:
18829630
50.

Spotlight on teriflunomide.

Tallantyre E, Evangelou N, Constantinescu CS.

Int MS J. 2008 Jun;15(2):62-8. Review.

PMID:
18782502

Supplemental Content

Loading ...
Support Center